Welcome to Endpts.com!

BREAKING NEWS: Biotech is HOT!

Headline	Date
PeopleIn­spir­na, which was prepar­ing for a Phase 3 can­cer tri­al, has fold­ed	17 hours ago
El­e­vate­Bio trims work­force by 17%	5 days ago
Covid con­trar­i­an Bhat­tacharya is con­firmed as NIH chief, tak­ing over at a fraught mo­ment for fed­er­al re­search	6 days ago
FinancingAl­pha­bet’s Iso­mor­phic Labs rais­es $600M in biotech’s largest round of 2025	21 hours ago
Ex­clu­sive: SV Health de­buts Parkin­son's biotech with back­ing from Ab­b­Vie and oth­ers	Yesterday
Galatea Bio gets $25M to map ge­net­ic di­ver­si­ty of 10 mil­lion peo­ple, help phar­ma cre­ate new med­i­cines	4 days ago
StartupsEx­clu­sive: Met­sera CEO on what it takes to build an obe­si­ty biotech in 2025	4 days ago
Au­ri­on CEO is out as Al­con takes ma­jor­i­ty stake in cell ther­a­py start­up	5 days ago
Lyn­dra Ther­a­peu­tics to wind down amid fund­ing hur­dles for long-act­ing drug tech­nol­o­gy	6 days ago
DealsBlue­bird gets new M&A bid, seek­ing to top pri­vate eq­ui­ty of­fer	3 days ago
No­vo inks sec­ond obe­si­ty deal of the week, with Lex­i­con oral drug part­ner­ship worth up to $1B	3 days ago
Be­fore Alu­mis went pub­lic via IPO, it tried do­ing a re­verse merg­er with Ace­lyrin	3 days ago

---

---

Check out these other hot topics!